Collegium Pharmaceutical's market cap is currently ―. The company's EPS TTM is $2.4; its P/E ratio is 13.87; Collegium Pharmaceutical is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $1.46. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	$ 144.92M	$ 149.75M	$ 136.71M	$ 135.55M	$ 144.77M
Gross Profit	$ 91.46M	$ 94.63M	$ 80.31M	$ 111.29M	$ 144.77M
EBIT	$ 53.96M	$ 65.99M	$ 49.55M	$ 77.12M	$ 3.87M
EBITDA	$ 90.76M	$ 102.85M	-	$ 117.64M	$ 44.44M
Net Income Common Stockholders	$ 27.71M	$ 31.94M	$ 20.63M	$ 13.01M	$ -17.43M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 318.05M	$ 310.55M	$ 304.56M	$ 325.47M	$ 269.48M
Total Assets	$ 1.11B	$ 1.14B	$ 1.18B	$ 1.21B	$ 1.21B
Total Debt	$ 629.99M	$ 674.28M	$ 718.39M	$ 762.35M	$ 806.24M
Net Debt	$ 311.94M	$ 363.74M	$ 413.82M	$ 436.88M	$ 536.76M
Total Liabilities	$ 892.08M	$ 947.88M	$ 998.71M	$ 1.01B	$ 1.03B
Stockholders Equity	$ 222.17M	$ 195.43M	$ 178.87M	$ 200.81M	$ 179.73M
Cash Flow	-
Free Cash Flow	$ 61.37M	$ 73.17M	-	$ 99.67M	$ 2.55M
Operating Cash Flow	$ 61.94M	$ 73.34M	$ 74.02M	$ 99.72M	$ 2.55M
Investing Cash Flow	$ -18.13M	$ -25.10M	$ -3.82M	$ -41.72M	$ -176.00K
Financing Cash Flow	$ -54.15M	$ -67.83M	$ -95.41M	$ -45.24M	$ 68.30M

Currency in USD

Collegium Pharmaceutical Earnings and Revenue History

Income Statement >

Collegium Pharmaceutical Debt to Assets

Balance Sheet >

Collegium Pharmaceutical Cash Flow

Cash Flow >

Collegium Pharmaceutical Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing